SE381053B - Forfaranden for framstellning av 4-(omega(kumarin-7-yl-oxi)-alkyl) -piperazin derivat - Google Patents

Forfaranden for framstellning av 4-(omega(kumarin-7-yl-oxi)-alkyl) -piperazin derivat

Info

Publication number
SE381053B
SE381053B SE7206101A SE610172A SE381053B SE 381053 B SE381053 B SE 381053B SE 7206101 A SE7206101 A SE 7206101A SE 610172 A SE610172 A SE 610172A SE 381053 B SE381053 B SE 381053B
Authority
SE
Sweden
Prior art keywords
cumarin
oxi
omega
procedures
alkyl
Prior art date
Application number
SE7206101A
Other languages
English (en)
Inventor
Ernst-Christian Witte
Kurt Stach
Max Thiel
Androniki Roesch
Egon Roesch
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of SE381053B publication Critical patent/SE381053B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7206101A 1971-05-14 1972-05-09 Forfaranden for framstellning av 4-(omega(kumarin-7-yl-oxi)-alkyl) -piperazin derivat SE381053B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712123924 DE2123924A1 (de) 1971-05-14 1971-05-14 4-eckige Klammer auf omega-(Camarin-7-yl-oxy)-alkyl eckige Klammer zu -piperazin-Derivate und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
SE381053B true SE381053B (sv) 1975-11-24

Family

ID=5807842

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7206101A SE381053B (sv) 1971-05-14 1972-05-09 Forfaranden for framstellning av 4-(omega(kumarin-7-yl-oxi)-alkyl) -piperazin derivat

Country Status (17)

Country Link
US (1) US3810898A (sv)
JP (3) JPS6127391B1 (sv)
AT (2) AT315171B (sv)
AU (1) AU461615B2 (sv)
BE (1) BE884459Q (sv)
CA (1) CA1005817A (sv)
CH (2) CH573429A5 (sv)
DE (1) DE2123924A1 (sv)
ES (1) ES402578A1 (sv)
FI (1) FI54307C (sv)
FR (1) FR2137731B1 (sv)
GB (1) GB1335946A (sv)
HU (1) HU163230B (sv)
NL (1) NL172953C (sv)
SE (1) SE381053B (sv)
YU (2) YU35017B (sv)
ZA (1) ZA723167B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2335432A1 (de) * 1973-07-12 1975-01-30 Boehringer Mannheim Gmbh 3,4-dihydro-2h-naphthalinon-(1)5-oxy-propyl-piperazin-derivate und verfahren zu ihrer herstellung
JPS54130587A (en) * 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
DE2964429D1 (en) 1978-10-20 1983-02-03 Beecham Group Plc Heterocyclic coumarin derivatives, their preparation and pharmaceutical compositions comprising said derivatives
DE2901336A1 (de) 1979-01-15 1980-07-24 Boehringer Mannheim Gmbh Neue arylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US4320128A (en) * 1979-03-24 1982-03-16 Beecham Group Limited Chromanone derivatives and compositions containing them
JPS6013788A (ja) * 1983-07-05 1985-01-24 Yamanouchi Pharmaceut Co Ltd 新規なクマリン誘導体
DE3427985A1 (de) * 1984-07-28 1986-01-30 Boehringer Mannheim Gmbh, 6800 Mannheim Neue 2h-l-benzopyran-2-on-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
US4701456A (en) * 1984-09-19 1987-10-20 Warner-Lambert Company Aminoalkoxybenzopyranones as antipsychotic and anxiolytic agents
GB8502267D0 (en) * 1985-01-30 1985-02-27 Pfizer Ltd Quinolone inotropic agents
DE4111861A1 (de) * 1991-04-11 1992-10-15 Schwabe Willmar Gmbh & Co Benzopyranone, verfahren zu ihrer herstellung und verwendung
US5166367A (en) * 1991-06-21 1992-11-24 American Home Products Corporation Antipsychotic benzodioxan derivatives
CN100393716C (zh) * 2006-05-18 2008-06-11 中国药科大学 香豆素衍生物、其制备方法及作为α1受体拮抗剂的用途

Also Published As

Publication number Publication date
AU4214072A (en) 1973-11-15
BE884459Q (fr) 1981-01-26
JPS58219176A (ja) 1983-12-20
CH573429A5 (sv) 1976-03-15
AU461615B2 (en) 1975-05-29
HU163230B (sv) 1973-07-28
ES402578A1 (es) 1975-04-01
CA1005817A (en) 1977-02-22
YU35017B (en) 1980-06-30
ZA723167B (en) 1973-03-28
AT315171B (de) 1974-05-10
FR2137731A1 (sv) 1972-12-29
YU125572A (en) 1979-12-31
DE2123924B2 (sv) 1980-05-29
CH573427A5 (sv) 1976-03-15
NL172953C (nl) 1983-11-16
FI54307B (fi) 1978-07-31
DE2123924A1 (de) 1972-11-23
FR2137731B1 (sv) 1975-10-17
GB1335946A (en) 1973-10-31
AT315173B (de) 1974-05-10
US3810898A (en) 1974-05-14
FI54307C (fi) 1978-11-10
JPS61263972A (ja) 1986-11-21
DE2123924C3 (sv) 1981-02-12
JPS6127391B1 (sv) 1986-06-25
NL172953B (nl) 1983-06-16
NL7206456A (sv) 1972-11-16
YU144778A (en) 1982-06-30

Similar Documents

Publication Publication Date Title
NO144568C (no) Analogifremgangsmaate til fremstilling av 3-substituerte 4-fenylpiperidiner
NO144223C (no) Fremgangsmaate til fremstilling av strekkbart papir
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE374375B (sv) Analogiforfarande for framstellning av nya 4-(3-karboxi-4-hydroxi-fenylazo)-bensensulfonamido-pyridiner
SE381052B (sv) Forfaranden for framstellning av 4-(omega(flavon-7-yl-oxi)-alkyl) -piperazinderivat
SE381053B (sv) Forfaranden for framstellning av 4-(omega(kumarin-7-yl-oxi)-alkyl) -piperazin derivat
SE391632B (sv) Forfarande for framstellning av kulturmjolkprodukter
SE395693B (sv) Saett att framstaella fenylpiperazinderivat
SE405598B (sv) Forfarande for framstellning av nya terapeutiskt verksamma derivat av 4-(3-amino-2-hydroxi-propoxi)-indol
SE381662B (sv) Forfarande for framstellning av nya pyridinderivat
SE380803B (sv) Forfarande for framstellning av kondenserade piperazinderivat
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE400764B (sv) Forfarande for framstellning av substituerade 3-hydroximetylisokinoliner
SE382980B (sv) Forfarande for framstellning av nya derivat av hexahydrofenantridin
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE393376B (sv) Forfarande for framstellning av pyrimidinonderivat
SE409858B (sv) Forfarande for framstallning av vissa angivna aminoalkylfenylacetonitrilderivat
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE401832B (sv) Forfarande for framstellning av derivat av 2-formyl-3-karbonamido-kinoxalin-di-n-oxider
SE385482B (sv) Forfarande for framstellning av basiskt substituerade 3-bensoyl-benso(b)tiofen-derivat
SE394680B (sv) Forfarande for framstellning av cykliska fosfamidderivat
SE384210B (sv) Forfarande for framstellning av nya nitrosokarbamidderivat
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE405730B (sv) Forfarande for framstellning av kinazolinderivat